- Home
- AUUD vs ENSC Comparison
AUUD vs ENSC Comparison
Compare AUUD & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- ENSC
- Stock Information
- Founded
- AUUD 2012
- ENSC 2003
- Country
- AUUD United States
- ENSC United States
- Employees
- AUUD N/A
- ENSC N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- ENSC Health Care
- Exchange
- AUUD Nasdaq
- ENSC Nasdaq
- Market Cap
- AUUD 2.9M
- ENSC 3.4M
- IPO Year
- AUUD 2021
- ENSC N/A
- Fundamental
- Price
- AUUD $4.45
- ENSC $2.34
- Analyst Decision
- AUUD
- ENSC
- Analyst Count
- AUUD 0
- ENSC 0
- Target Price
- AUUD N/A
- ENSC N/A
- AVG Volume (30 Days)
- AUUD 188.4K
- ENSC 5.0M
- Earning Date
- AUUD 05-27-2025
- ENSC 05-13-2025
- Dividend Yield
- AUUD N/A
- ENSC N/A
- EPS Growth
- AUUD N/A
- ENSC N/A
- EPS
- AUUD N/A
- ENSC N/A
- Revenue
- AUUD N/A
- ENSC $6,224,081.00
- Revenue This Year
- AUUD N/A
- ENSC N/A
- Revenue Next Year
- AUUD N/A
- ENSC N/A
- P/E Ratio
- AUUD N/A
- ENSC N/A
- Revenue Growth
- AUUD N/A
- ENSC 256.35
- 52 Week Low
- AUUD $2.88
- ENSC $1.62
- 52 Week High
- AUUD $31.62
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- AUUD 58.40
- ENSC 46.40
- Support Level
- AUUD $3.82
- ENSC $1.99
- Resistance Level
- AUUD $4.73
- ENSC $2.40
- Average True Range (ATR)
- AUUD 0.39
- ENSC 0.26
- MACD
- AUUD 0.15
- ENSC 0.02
- Stochastic Oscillator
- AUUD 76.24
- ENSC 28.00
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.